Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...
"With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks or even months for it to be most effective," said study author Richard B.
Patients taking Qulipta had a 37% to 61% lower risk for experiencing migraine from the very first day they started taking the drug, according to a new report in the journal Neurology.